View Future GrowthWacker Chemie 過去の業績過去 基準チェック /06Wacker Chemieの収益は年間平均-45.8%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間4.4% 2.9%割合で 減少しています。主要情報-45.84%収益成長率-45.88%EPS成長率Chemicals 業界の成長12.41%収益成長率-2.91%株主資本利益率-20.60%ネット・マージン-14.83%次回の業績アップデート30 Jul 2026最近の業績更新お知らせ • Dec 02+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2025 Results on Mar 11, 2026Wacker Chemie AG announced that they will report fiscal year 2025 results on Mar 11, 2026Reported Earnings • Oct 29Third quarter 2024 earnings: Revenues in line with analyst expectationsThird quarter 2024 results: Revenue: €1.49b (down 2.2% from 3Q 2023). Net income: €44.2m (up 58% from 3Q 2023). Profit margin: 3.0% (up from 1.8% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany.お知らせ • Oct 23+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2024 Results on Mar 12, 2025Wacker Chemie AG announced that they will report fiscal year 2024 results on Mar 12, 2025Reported Earnings • Jul 28Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: €0.58 (down from €2.38 in 2Q 2023). Revenue: €1.47b (down 16% from 2Q 2023). Net income: €29.0m (down 75% from 2Q 2023). Profit margin: 2.0% (down from 6.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 3.5%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 26First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2024 results: EPS: €0.89 (down from €2.90 in 1Q 2023). Revenue: €1.49b (down 15% from 1Q 2023). Net income: €44.2m (down 69% from 1Q 2023). Profit margin: 3.0% (down from 8.3% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 71%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 7% per year.お知らせ • Oct 27+ 4 more updatesWacker Chemie AG to Report Q2, 2024 Results on Jul 26, 2024Wacker Chemie AG announced that they will report Q2, 2024 results on Jul 26, 2024すべての更新を表示Recent updatesお知らせ • Mar 23Wacker Chemie AG, Annual General Meeting, May 06, 2026Wacker Chemie AG, Annual General Meeting, May 06, 2026, at 10:00 W. Europe Standard Time.お知らせ • Dec 02+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2025 Results on Mar 11, 2026Wacker Chemie AG announced that they will report fiscal year 2025 results on Mar 11, 2026お知らせ • Sep 22Wacker Chemie AG(XTRA:WCH) dropped from FTSE All-World Index (USD)Wacker Chemie AG(XTRA:WCH) dropped from FTSE All-World Index (USD)お知らせ • Mar 25Wacker Chemie AG, Annual General Meeting, May 07, 2025Wacker Chemie AG, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time.お知らせ • Mar 13Wacker Chemie AG announces Annual dividend, payable on May 06, 2025Wacker Chemie AG announced Annual dividend of EUR 2.5000 per share payable on May 06, 2025, ex-date on May 02, 2025 and record date on May 05, 2025.Reported Earnings • Oct 29Third quarter 2024 earnings: Revenues in line with analyst expectationsThird quarter 2024 results: Revenue: €1.49b (down 2.2% from 3Q 2023). Net income: €44.2m (up 58% from 3Q 2023). Profit margin: 3.0% (up from 1.8% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany.お知らせ • Oct 23+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2024 Results on Mar 12, 2025Wacker Chemie AG announced that they will report fiscal year 2024 results on Mar 12, 2025Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €93.62, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 29% over the past three years.Reported Earnings • Jul 28Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: €0.58 (down from €2.38 in 2Q 2023). Revenue: €1.47b (down 16% from 2Q 2023). Net income: €29.0m (down 75% from 2Q 2023). Profit margin: 2.0% (down from 6.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 3.5%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 26First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2024 results: EPS: €0.89 (down from €2.90 in 1Q 2023). Revenue: €1.49b (down 15% from 1Q 2023). Net income: €44.2m (down 69% from 1Q 2023). Profit margin: 3.0% (down from 8.3% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 71%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 7% per year.Declared Dividend • Mar 14Dividend of €3.00 announcedShareholders will receive a dividend of €3.00. Ex-date: 9th May 2024 Payment date: 13th May 2024 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (48% earnings payout ratio) and cash flows (50% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 56% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Price Target Changed • Jan 17Price target decreased by 9.1% to €124Down from €137, the current price target is an average from 14 analysts. New target price is 28% above last closing price of €96.88. Stock is down 31% over the past year. The company is forecast to post earnings per share of €6.01 for next year compared to €25.18 last year.お知らせ • Oct 27+ 4 more updatesWacker Chemie AG to Report Q2, 2024 Results on Jul 26, 2024Wacker Chemie AG announced that they will report Q2, 2024 results on Jul 26, 2024Reported Earnings • Oct 27Third quarter 2023 earnings: EPS misses analyst expectationsThird quarter 2023 results: EPS: €0.56 (down from €5.08 in 3Q 2022). Revenue: €1.52b (down 29% from 3Q 2022). Net income: €33.5m (down 87% from 3Q 2022). Profit margin: 2.2% (down from 12% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 7.4%. Revenue is forecast to stay flat during the next 3 years compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.9% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 7.6% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (130% cash payout ratio). Profit margins are more than 30% lower than last year (9.9% net profit margin).Reported Earnings • Jul 30Second quarter 2023 earnings: EPS exceeds analyst expectationsSecond quarter 2023 results: EPS: €2.38 (down from €7.67 in 2Q 2022). Revenue: €1.75b (down 19% from 2Q 2022). Net income: €118.1m (down 69% from 2Q 2022). Profit margin: 6.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 2.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 21Wacker Chemie AG Lowers Sales Guidance for the Year 2023Wacker Chemie AG lowered sales guidance for the year 2023. The company now has the following expectations: Group sales for 2023 are likely to come in between EUR 6.5 billion and EUR 6.8 billion (previous guidance: between EUR 7 billion and EUR 7.5 billion).New Risk • Jul 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 22% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (129% cash payout ratio). Share price has been volatile over the past 3 months (6.5% average weekly change).お知らせ • May 18+ 1 more updateWacker Chemie AG Announces Management ChangesThe Annual Shareholders' Meeting of Wacker Chemie AG approved Patrick Cramer is a new member of the Supervisory Board. He succeeds Franz-Josef Kortüm, a long-standing member of the Supervisory Board who stepped down at the end of the Annual Shareholders' Meeting for reasons of age. Cramer has a doctorate in biochemistry and is a former professor and dean at Ludwig-Maximilians-Universität in Munich. He currently works as director of the Max Planck Institute for Multidisciplinary Sciences in Göttingen. Cramer will take up his new assignment as president of the Max Planck Society in Munich at the end of June. The Supervisory Board's proposal to elect Prof. Andreas H. Biagosch, Dr. Gregor Biebl, Matthias Biebl, Prof. Patrick Cramer, Ann-Sophie Wacker, Dr. Peter-Alexander Wacker, Prof. Anna Weber and Dr. Susanne Weiss to the Supervisory Board until the 2028 Annual Shareholders' Meeting was adopted.Upcoming Dividend • May 12Upcoming dividend of €12.00 per share at 8.6% yieldEligible shareholders must have bought the stock before 19 May 2023. Payment date: 23 May 2023. Payout ratio is a comfortable 48% and the cash payout ratio is 85%. Trailing yield: 8.6%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.6%).お知らせ • May 10Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million.Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million on May 5, 2023. WACKER will continue and grow existing customer relationships maintained by ADL BioPharma in its capacity as CMO for fermentation-based products for the food, pharmaceutical and consumer goods industries. Wacker Chemie AG completed the acquisition of Biotechnology Assets, S.A from Kartesia Advisor LLP on May 5, 2023.Reported Earnings • Mar 16Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €25.18 (up from €16.24 in FY 2021). Revenue: €8.21b (up 32% from FY 2021). Net income: €1.25b (up 55% from FY 2021). Profit margin: 15% (up from 13% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.4%. Revenue is expected to decline by 2.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 64% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 13Investor sentiment improved over the past weekAfter last week's 16% share price gain to €132, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 119% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €127 per share.Buying Opportunity • Nov 08Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be €149, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 102%. Revenue is forecast to decline by 11% in 2 years. Earnings is forecast to decline by 56% in the next 2 years.お知らせ • Oct 14+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2022 Final Results on Mar 14, 2023Wacker Chemie AG announced that they will report fiscal year 2022 final results on Mar 14, 2023Reported Earnings • Aug 03Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: €7.66 (up from €3.69 in 2Q 2021). Revenue: €2.17b (up 45% from 2Q 2021). Net income: €371.8m (up 112% from 2Q 2021). Profit margin: 17% (up from 12% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 1.1%, compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • May 16Upcoming dividend of €8.00 per shareEligible shareholders must have bought the stock before 23 May 2022. Payment date: 25 May 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.3%). In line with average of industry peers (5.1%).Reported Earnings • May 02First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €7.92 (up from €2.06 in 1Q 2021). Revenue: €2.08b (up 53% from 1Q 2021). Net income: €402.6m (up 278% from 1Q 2021). Profit margin: 19% (up from 7.8% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.0%. Earnings per share (EPS) also surpassed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 7.8%, compared to a 8.9% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 18Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €6.21b (up 32% from FY 2020). Net income: €806.9m (up 327% from FY 2020). Profit margin: 13% (up from 4.0% in FY 2020). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 7.9%, compared to a 5.3% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 23% per year.Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improved over the past weekAfter last week's 16% share price gain to €130, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 43% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €119 per share.Valuation Update With 7 Day Price Move • Jan 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €125, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €214 per share.Buying Opportunity • Jan 18Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.3%. The fair value is estimated to be €189, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. The company has become profitable over the last year.Reported Earnings • Oct 30Third quarter 2021 earnings released: EPS €4.90 (vs €1.30 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €1.66b (up 40% from 3Q 2020). Net income: €248.7m (up 267% from 3Q 2020). Profit margin: 15% (up from 5.7% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.Executive Departure • May 14CEO, President & Member of Executive Board Rudolf Staudigl has left the companyOn the 12th of May, Rudolf Staudigl's tenure as CEO, President & Member of Executive Board of the company ended after 13.0 years in the role. We don't have any record of a personal shareholding under Rudolf's name. A total of 3 executives have left over the last 12 months. Under Rudolf's leadership, the company delivered a total shareholder return of -0.9%.Upcoming Dividend • May 06Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 13 May 2021. Payment date: 17 May 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).Reported Earnings • May 03First quarter 2021 earnings released: EPS €2.06 (vs €1.31 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €1.36b (up 14% from 1Q 2020). Net income: €106.6m (up 55% from 1Q 2020). Profit margin: 7.8% (up from 5.8% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 18Full year 2020 earnings releasedThe company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €4.69b (down 4.8% from FY 2019). Net income: €189.2m (up €831.8m from FY 2019). Profit margin: 4.0% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 108 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Feb 03New 90-day high: €128The company is up 50% from its price of €85.26 on 05 November 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €56.09 per share.収支内訳Wacker Chemie の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:WCH 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Mar 265,413-80355521031 Dec 255,485-82156421530 Sep 255,5662257421430 Jun 255,65613658421331 Mar 255,71118958520931 Dec 245,72224157420430 Sep 245,77012456019930 Jun 245,86312454419431 Mar 246,14821454119031 Dec 236,40231454018430 Sep 236,84651555318330 Jun 237,45673956718431 Mar 237,8771,00255918231 Dec 228,2091,25154817830 Sep 228,0711,29252717330 Jun 227,5971,29950216531 Mar 226,9241,08748816531 Dec 216,20880747516430 Sep 215,75858245815730 Jun 215,28340346016131 Mar 214,85422745815731 Dec 204,69218945815730 Sep 204,609-61949517330 Jun 204,693-59947416031 Mar 204,889-56849517331 Dec 194,928-64349517330 Sep 194,96113550817730 Jun 194,93611750917531 Mar 194,99716350517131 Dec 184,97924649616530 Sep 184,96627149115830 Jun 185,03530848115431 Mar 184,92328747515231 Dec 174,92423247315330 Sep 174,90020146515630 Jun 174,73916045615731 Mar 174,72015743715531 Dec 164,63416842315030 Sep 164,71615344515630 Jun 164,92315445616231 Mar 165,09420847516831 Dec 155,29624749017530 Sep 155,25822547417930 Jun 155,132285465180質の高い収益: WCHは現在利益が出ていません。利益率の向上: WCHは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: WCHは利益が出ておらず、過去 5 年間で損失は年間45.8%の割合で増加しています。成長の加速: WCHの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: WCHは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( -13.5% ) と比較することは困難です。株主資本利益率高いROE: WCHは現在利益が出ていないため、自己資本利益率 ( -20.6% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/09 06:26終値2026/06/09 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Wacker Chemie AG 13 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。31 アナリスト機関Gerhard SchwarzBaader Helvea Equity ResearchKonstantin WiechertBaader Helvea Equity ResearchLaura Lopez PinedaBaader Helvea Equity Research28 その他のアナリストを表示
お知らせ • Dec 02+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2025 Results on Mar 11, 2026Wacker Chemie AG announced that they will report fiscal year 2025 results on Mar 11, 2026
Reported Earnings • Oct 29Third quarter 2024 earnings: Revenues in line with analyst expectationsThird quarter 2024 results: Revenue: €1.49b (down 2.2% from 3Q 2023). Net income: €44.2m (up 58% from 3Q 2023). Profit margin: 3.0% (up from 1.8% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany.
お知らせ • Oct 23+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2024 Results on Mar 12, 2025Wacker Chemie AG announced that they will report fiscal year 2024 results on Mar 12, 2025
Reported Earnings • Jul 28Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: €0.58 (down from €2.38 in 2Q 2023). Revenue: €1.47b (down 16% from 2Q 2023). Net income: €29.0m (down 75% from 2Q 2023). Profit margin: 2.0% (down from 6.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 3.5%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 26First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2024 results: EPS: €0.89 (down from €2.90 in 1Q 2023). Revenue: €1.49b (down 15% from 1Q 2023). Net income: €44.2m (down 69% from 1Q 2023). Profit margin: 3.0% (down from 8.3% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 71%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 7% per year.
お知らせ • Oct 27+ 4 more updatesWacker Chemie AG to Report Q2, 2024 Results on Jul 26, 2024Wacker Chemie AG announced that they will report Q2, 2024 results on Jul 26, 2024
お知らせ • Mar 23Wacker Chemie AG, Annual General Meeting, May 06, 2026Wacker Chemie AG, Annual General Meeting, May 06, 2026, at 10:00 W. Europe Standard Time.
お知らせ • Dec 02+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2025 Results on Mar 11, 2026Wacker Chemie AG announced that they will report fiscal year 2025 results on Mar 11, 2026
お知らせ • Sep 22Wacker Chemie AG(XTRA:WCH) dropped from FTSE All-World Index (USD)Wacker Chemie AG(XTRA:WCH) dropped from FTSE All-World Index (USD)
お知らせ • Mar 25Wacker Chemie AG, Annual General Meeting, May 07, 2025Wacker Chemie AG, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time.
お知らせ • Mar 13Wacker Chemie AG announces Annual dividend, payable on May 06, 2025Wacker Chemie AG announced Annual dividend of EUR 2.5000 per share payable on May 06, 2025, ex-date on May 02, 2025 and record date on May 05, 2025.
Reported Earnings • Oct 29Third quarter 2024 earnings: Revenues in line with analyst expectationsThird quarter 2024 results: Revenue: €1.49b (down 2.2% from 3Q 2023). Net income: €44.2m (up 58% from 3Q 2023). Profit margin: 3.0% (up from 1.8% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany.
お知らせ • Oct 23+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2024 Results on Mar 12, 2025Wacker Chemie AG announced that they will report fiscal year 2024 results on Mar 12, 2025
Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €93.62, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 29% over the past three years.
Reported Earnings • Jul 28Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: €0.58 (down from €2.38 in 2Q 2023). Revenue: €1.47b (down 16% from 2Q 2023). Net income: €29.0m (down 75% from 2Q 2023). Profit margin: 2.0% (down from 6.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 3.5%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 26First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2024 results: EPS: €0.89 (down from €2.90 in 1Q 2023). Revenue: €1.49b (down 15% from 1Q 2023). Net income: €44.2m (down 69% from 1Q 2023). Profit margin: 3.0% (down from 8.3% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 71%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 7% per year.
Declared Dividend • Mar 14Dividend of €3.00 announcedShareholders will receive a dividend of €3.00. Ex-date: 9th May 2024 Payment date: 13th May 2024 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (48% earnings payout ratio) and cash flows (50% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 56% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Price Target Changed • Jan 17Price target decreased by 9.1% to €124Down from €137, the current price target is an average from 14 analysts. New target price is 28% above last closing price of €96.88. Stock is down 31% over the past year. The company is forecast to post earnings per share of €6.01 for next year compared to €25.18 last year.
お知らせ • Oct 27+ 4 more updatesWacker Chemie AG to Report Q2, 2024 Results on Jul 26, 2024Wacker Chemie AG announced that they will report Q2, 2024 results on Jul 26, 2024
Reported Earnings • Oct 27Third quarter 2023 earnings: EPS misses analyst expectationsThird quarter 2023 results: EPS: €0.56 (down from €5.08 in 3Q 2022). Revenue: €1.52b (down 29% from 3Q 2022). Net income: €33.5m (down 87% from 3Q 2022). Profit margin: 2.2% (down from 12% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 7.4%. Revenue is forecast to stay flat during the next 3 years compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.9% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 7.6% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (130% cash payout ratio). Profit margins are more than 30% lower than last year (9.9% net profit margin).
Reported Earnings • Jul 30Second quarter 2023 earnings: EPS exceeds analyst expectationsSecond quarter 2023 results: EPS: €2.38 (down from €7.67 in 2Q 2022). Revenue: €1.75b (down 19% from 2Q 2022). Net income: €118.1m (down 69% from 2Q 2022). Profit margin: 6.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 2.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 21Wacker Chemie AG Lowers Sales Guidance for the Year 2023Wacker Chemie AG lowered sales guidance for the year 2023. The company now has the following expectations: Group sales for 2023 are likely to come in between EUR 6.5 billion and EUR 6.8 billion (previous guidance: between EUR 7 billion and EUR 7.5 billion).
New Risk • Jul 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 22% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (129% cash payout ratio). Share price has been volatile over the past 3 months (6.5% average weekly change).
お知らせ • May 18+ 1 more updateWacker Chemie AG Announces Management ChangesThe Annual Shareholders' Meeting of Wacker Chemie AG approved Patrick Cramer is a new member of the Supervisory Board. He succeeds Franz-Josef Kortüm, a long-standing member of the Supervisory Board who stepped down at the end of the Annual Shareholders' Meeting for reasons of age. Cramer has a doctorate in biochemistry and is a former professor and dean at Ludwig-Maximilians-Universität in Munich. He currently works as director of the Max Planck Institute for Multidisciplinary Sciences in Göttingen. Cramer will take up his new assignment as president of the Max Planck Society in Munich at the end of June. The Supervisory Board's proposal to elect Prof. Andreas H. Biagosch, Dr. Gregor Biebl, Matthias Biebl, Prof. Patrick Cramer, Ann-Sophie Wacker, Dr. Peter-Alexander Wacker, Prof. Anna Weber and Dr. Susanne Weiss to the Supervisory Board until the 2028 Annual Shareholders' Meeting was adopted.
Upcoming Dividend • May 12Upcoming dividend of €12.00 per share at 8.6% yieldEligible shareholders must have bought the stock before 19 May 2023. Payment date: 23 May 2023. Payout ratio is a comfortable 48% and the cash payout ratio is 85%. Trailing yield: 8.6%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.6%).
お知らせ • May 10Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million.Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million on May 5, 2023. WACKER will continue and grow existing customer relationships maintained by ADL BioPharma in its capacity as CMO for fermentation-based products for the food, pharmaceutical and consumer goods industries. Wacker Chemie AG completed the acquisition of Biotechnology Assets, S.A from Kartesia Advisor LLP on May 5, 2023.
Reported Earnings • Mar 16Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €25.18 (up from €16.24 in FY 2021). Revenue: €8.21b (up 32% from FY 2021). Net income: €1.25b (up 55% from FY 2021). Profit margin: 15% (up from 13% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.4%. Revenue is expected to decline by 2.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 64% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 13Investor sentiment improved over the past weekAfter last week's 16% share price gain to €132, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 119% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €127 per share.
Buying Opportunity • Nov 08Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be €149, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 102%. Revenue is forecast to decline by 11% in 2 years. Earnings is forecast to decline by 56% in the next 2 years.
お知らせ • Oct 14+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2022 Final Results on Mar 14, 2023Wacker Chemie AG announced that they will report fiscal year 2022 final results on Mar 14, 2023
Reported Earnings • Aug 03Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: €7.66 (up from €3.69 in 2Q 2021). Revenue: €2.17b (up 45% from 2Q 2021). Net income: €371.8m (up 112% from 2Q 2021). Profit margin: 17% (up from 12% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 1.1%, compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • May 16Upcoming dividend of €8.00 per shareEligible shareholders must have bought the stock before 23 May 2022. Payment date: 25 May 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.3%). In line with average of industry peers (5.1%).
Reported Earnings • May 02First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €7.92 (up from €2.06 in 1Q 2021). Revenue: €2.08b (up 53% from 1Q 2021). Net income: €402.6m (up 278% from 1Q 2021). Profit margin: 19% (up from 7.8% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.0%. Earnings per share (EPS) also surpassed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 7.8%, compared to a 8.9% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 18Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €6.21b (up 32% from FY 2020). Net income: €806.9m (up 327% from FY 2020). Profit margin: 13% (up from 4.0% in FY 2020). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 7.9%, compared to a 5.3% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 23% per year.
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improved over the past weekAfter last week's 16% share price gain to €130, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 43% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €119 per share.
Valuation Update With 7 Day Price Move • Jan 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €125, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €214 per share.
Buying Opportunity • Jan 18Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.3%. The fair value is estimated to be €189, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. The company has become profitable over the last year.
Reported Earnings • Oct 30Third quarter 2021 earnings released: EPS €4.90 (vs €1.30 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €1.66b (up 40% from 3Q 2020). Net income: €248.7m (up 267% from 3Q 2020). Profit margin: 15% (up from 5.7% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.
Executive Departure • May 14CEO, President & Member of Executive Board Rudolf Staudigl has left the companyOn the 12th of May, Rudolf Staudigl's tenure as CEO, President & Member of Executive Board of the company ended after 13.0 years in the role. We don't have any record of a personal shareholding under Rudolf's name. A total of 3 executives have left over the last 12 months. Under Rudolf's leadership, the company delivered a total shareholder return of -0.9%.
Upcoming Dividend • May 06Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 13 May 2021. Payment date: 17 May 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).
Reported Earnings • May 03First quarter 2021 earnings released: EPS €2.06 (vs €1.31 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €1.36b (up 14% from 1Q 2020). Net income: €106.6m (up 55% from 1Q 2020). Profit margin: 7.8% (up from 5.8% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 18Full year 2020 earnings releasedThe company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €4.69b (down 4.8% from FY 2019). Net income: €189.2m (up €831.8m from FY 2019). Profit margin: 4.0% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 108 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Feb 03New 90-day high: €128The company is up 50% from its price of €85.26 on 05 November 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €56.09 per share.